Buy, Sell, Or Hold Amgen Stock At $270?
26/6 04:47
Amgen stock (NASDAQ:AMGN) declined 6% on Monday, June 23, 2025, following the release of mid-stage clinical trial results for its long-acting obesity drug candidate, MariTide. The data indicated the need for a low initial dosage to reduce side effects like vomiting. Amgen intends...